Showing results (71-80 of 175) with videos related to

Sort By:
Pageof 18
Clinical and Experimental Rheumatology|December 7, 2021
The safety and effectiveness of tocilizumab in elderly patients with rheumatoid arthritis and in patients with comorbidities associated with ageChristof Specker, Martin Aringer, Gerd-Rüdiger Burmester, et al.
Rheumatology International|April 4, 2016
Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patientsGoitybell Martínez, Jorge A Gómez, Holger Bang, et al.
European Journal of Immunology|March 25, 2010
Class switching and consecutive loss of dsDNA-reactive B1a B cells from the peritoneal cavity during murine lupus developmentPhilipp Enghard, Jens Y Humrich, Vantrung T Chu, et al.
Arthritis Research & Therapy|February 12, 2011
Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosusFidan Barkhudarova, Cornelia Dähnrich, Anke Rosemann, et al.
Arthritis Research & Therapy|April 19, 2015
The cellular signature of urinary immune cells in Lupus nephritis: new insights into potential biomarkersKatharina Kopetschke, Jan Klocke, Anna-Sophie Grießbach, et al.
Rheumatology (Oxford, England)|October 31, 2015
ROUTINE-a prospective, multicentre, non-interventional, observational study to evaluate the safety and effectiveness of intravenous tocilizumab for the treatment of active rheumatoid arthritis in daily practice in GermanyChristof Iking-Konert, Ulrich von Hinüber, Constanze Richter, et al.
Cells|October 17, 2019
IL-2 Therapy Diminishes Renal Inflammation and the Activity of Kidney-Infiltrating CD4+ T Cells in Murine Lupus NephritisAngelika Rose, Caroline von Spee-Mayer, Lutz Kloke, et al.
Arthritis Research & Therapy|March 11, 2010
Automated evaluation of autoantibodies on human epithelial-2 cells as an approach to standardize cell-based immunofluorescence testsKarl Egerer, Dirk Roggenbuck, Rico Hiemann, et al.
Rheumatology International|April 9, 2011
Effect of biofeedback and deep oscillation on Raynaud's phenomenon secondary to systemic sclerosis: results of a controlled prospective randomized clinical trialBirte Sporbeck, Kirsten Mathiske-Schmidt, Silke Jahr, et al.
Immunology Letters|April 6, 2010
Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cellsCornelia M Spies, Timo Gaber, Martin Hahne, et al.
Pageof 18